Fiscal year ending 2022. Filed on November 16, 2023.
165 West End Ave Apt 14ab
New York, New York 10023
Action to Cure Kidney Cancer (EIN: 20-0441399) has filed an IRS Form 990 between fiscal years 2022 and 2024. In its fiscal year 2022 IRS Form 990 filing, Action to Cure Kidney Cancer, a 501(c)(3) charitable organization, reported compensation for 4 employees. Among the employees shown here, the average compensation is $0.
Revenue
Expenses
Employee compensation
ACKC WAS FOUNDED IN ORDER TO EDUCATE THE KIDNEY CANCER PATIENTS, CAREGIVERS AND THE GENERAL PUBLIC ABOUT THE DISEASE; INCREASE FEDERAL FUNDING FOR CANCER RESEARCH; GIVE MODEST GRANTS TO PROMISING YOUNG INVESTIGATORS; PUBLICIZE THE CAUSES AND PREVENTIONS OF KIDNEY CANCER; NEGOTIATE WITH DRUG COMPANIES WITH RESPECT TO TESTING THEIR PRODUCTS IN KIDNEY CANCER PATIENTS.ACKC MOSTLY FUNDS GRANTS WHOSE RESEARCH BIG PHARMA DOES NOT FIND PROFITABLE AND, OVER THE YEARS, WE'VE ISSUED GRANTS IN THE AMOUNT OF $400,000 TO KIDNEY CANCER INVESTIGATORS. WE CONCENTRATE ON RAISING THE AWARENESS OF CAUSES SUCH AS PFAS CHEMICALS,AND PROMOTE EARLY DETECTION AND LIFESTYLE CHANGES SINCE WHEN KIDNEY CANCER IS DISCOVERED AT AN EARLY STAGE, THE SURVIVAL POTENTIAL IS HIGHER.FINALLY, WE LOBBY CONGRESS TO APPROPRIATE RESEARCH MONEY FOR KIDNEY CANCER. IN 2006, WERE SUCCESSFUL IN HAVING CONGRESS INCLUDE KIDNEY CANCER IN THE DEPARTMENT OF DEFENSE'S PEER REVIEW CANCER RESEARCH
Be the first to know when new IRS Form 990 data is published for this organization.